Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-21-021393
Filing Date
2021-03-17
Accepted
2021-03-17 16:56:03
Documents
1
Period of Report
2021-03-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3871
  Complete submission text file 0001209191-21-021393.txt   5488
Mailing Address 520 PIKE STREET SUITE 2250 SEATTLE WA 98101
Business Address 520 PIKE STREET SUITE 2250 SEATTLE WA 98101 425-686-1500
ACHIEVE LIFE SCIENCES, INC. (Issuer) CIK: 0000949858 (see all company filings)

EIN.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address C/O KURA ONCOLOGY, INC. 3033 SCIENCE PARK RD, SUITE 220 SAN DIEGO CA 92121
Business Address
Martell Bridget A (Reporting) CIK: 0001629627 (see all company filings)

Type: 4 | Act: 34 | File No.: 033-80623 | Film No.: 21751228